Market Value1,531,129,746
Total Holdings64
File Date2025-05-15
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
EW / Edwards Lifesciences Corporation
ACHV / Achieve Life Sciences, Inc.
LUNG / Pulmonx Corporation
NARI / Inari Medical, Inc.
AVTR / Avantor, Inc.
GMED / Globus Medical, Inc.
INCY / Incyte Corporation
AXSM / Axsome Therapeutics, Inc.
RNA / Avidity Biosciences, Inc.
ABBV / AbbVie Inc.
RYTM / Rhythm Pharmaceuticals, Inc.
ERAS / Erasca, Inc.
BIOA / BioAge Labs, Inc.
INBX / Inhibrx Biosciences, Inc.
MTSR / Metsera, Inc.
BMY / Bristol-Myers Squibb Company
EWTX / Edgewise Therapeutics, Inc. Put
SLNO / Soleno Therapeutics, Inc.
PTCT / PTC Therapeutics, Inc.
SLNO / Soleno Therapeutics, Inc. Put
IMTX / Immatics N.V.
SNDX / Syndax Pharmaceuticals, Inc.
IMNM / Immunome, Inc.
GPCR / Structure Therapeutics Inc. - Depositary Receipt (Common Stock)
PHVS / Pharvaris N.V.
AVBP / ArriVent BioPharma, Inc.
IRON / Disc Medicine, Inc.
RCUS / Arcus Biosciences, Inc.
AZN / AstraZeneca PLC - Depositary Receipt (Common Stock)
BSX / Boston Scientific Corporation
RAPP / Rapport Therapeutics, Inc.
ESTA / Establishment Labs Holdings Inc.
AXSM / Axsome Therapeutics, Inc. Call
IDYA / IDEAYA Biosciences, Inc.
ALKS / Alkermes plc
BDX / Becton, Dickinson and Company
TVTX / Travere Therapeutics, Inc.
JANX / Janux Therapeutics, Inc.
ICUI / ICU Medical, Inc.
EXAS / Exact Sciences Corporation
QQQ / Invesco QQQ Trust, Series 1 Put
SVRA / Savara Inc.
PEN / Penumbra, Inc.
VERA / Vera Therapeutics, Inc.
GILD / Gilead Sciences, Inc.
SYK / Stryker Corporation
SRRK / Scholar Rock Holding Corporation
ALNY / Alnylam Pharmaceuticals, Inc.
QURE / uniQure N.V.
AKRO / Akero Therapeutics, Inc.
SUPN / Supernus Pharmaceuticals, Inc.
IWM / iShares Trust - iShares Russell 2000 ETF Put
ACAD / ACADIA Pharmaceuticals Inc. Call
YMAB / Y-mAbs Therapeutics, Inc.
LLY / Eli Lilly and Company
ELVN / Enliven Therapeutics, Inc.
VIR / Vir Biotechnology, Inc.
PRAX / Praxis Precision Medicines, Inc.
INSM / Insmed Incorporated
COGT / Cogent Biosciences, Inc.
KROS / Keros Therapeutics, Inc.
DHR / Danaher Corporation
BOLT / Bolt Biotherapeutics, Inc.
BBIO / BridgeBio Pharma, Inc.
DYN / Dyne Therapeutics, Inc.
JAZZ / Jazz Pharmaceuticals plc
ANAB / AnaptysBio, Inc.
REPL / Replimune Group, Inc.
ROIV / Roivant Sciences Ltd.
IKNA / Ikena Oncology, Inc.
NTRA / Natera, Inc.
AVTE / Aerovate Therapeutics, Inc.
MDT / Medtronic plc
ISRG / Intuitive Surgical, Inc.
KURA / Kura Oncology, Inc.
BPMC / Blueprint Medicines Corporation
SRPT / Sarepta Therapeutics, Inc.
INZY / Inozyme Pharma, Inc.
DXCM / DexCom, Inc.
EWTX / Edgewise Therapeutics, Inc.
NXTC / NextCure, Inc.